Nuformix plc
NFX.L · LSE
3/31/2025 | 9/30/2024 | 3/31/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | £15 | £0 | £9 | £18 |
| Gross Profit | -£15 | £0 | -£9 | -£18 |
| % Margin | – | – | – | – |
| R&D Expenses | £0 | £71 | £0 | £0 |
| G&A Expenses | £0 | £506 | £0 | £0 |
| SG&A Expenses | £0 | £506 | £0 | £263 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £3,067 | £0 | £0 |
| Operating Expenses | £0 | £3,644 | £0 | £263 |
| Operating Income | -£0 | -£3,644 | -£0 | -£281 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | £0 | £0 | £0 | £0 |
| Pre-Tax Income | -£0 | -£3,644 | -£0 | -£281 |
| Tax Expense | £0 | -£6 | £0 | -£46 |
| Net Income | -£0 | -£3,638 | -£0 | -£235 |
| % Margin | – | – | – | – |
| EPS | -0 | -0 | -0 | -0 |
| % Growth | 25% | -124,743.9% | 99.9% | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| Weighted Avg Shares Out | 1,375 | 787,008 | 756,945 | 734,545 |
| Weighted Avg Shares Out Dil | 1,374 | 786,932 | 756,945 | 734,545 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £29 | £9 | £18 |
| EBITDA | -£0 | -£477 | -£0 | -£263 |
| % Margin | – | – | – | – |